These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Spread-out antiproton beams deliver poor physical dose distributions for radiation therapy. Paganetti H, Goitein M, Parodi K. Radiother Oncol; 2010 Apr; 95(1):79-86. PubMed ID: 19394098 [Abstract] [Full Text] [Related]
5. Calculated LET spectrum from antiproton beams stopping in water. Bassler N, Holzscheiter M. Acta Oncol; 2009 Apr; 48(2):223-6. PubMed ID: 18932095 [Abstract] [Full Text] [Related]
6. The biological effectiveness of antiproton irradiation. Holzscheiter MH, Bassler N, Agazaryan N, Beyer G, Blackmore E, DeMarco JJ, Doser M, Durand RE, Hartley O, Iwamoto KS, Knudsen HV, Landua R, Maggiore C, McBride WH, Møller SP, Petersen J, Skarsgard LD, Smathers JB, Solberg TD, Uggerhøj UI, Vranjes S, Withers HR, Wong M, Wouters BG. Radiother Oncol; 2006 Dec; 81(3):233-42. PubMed ID: 17069916 [Abstract] [Full Text] [Related]
7. V-79 Chinese hamster cells irradiated with antiprotons, a study of peripheral damage due to medium and long range components of the annihilation radiation. Kovacevic S, Bassler N, Hartley O, Knudsen H, Vranjes S, Garaj-Vrhovac V, Holzscheiter M. Int J Radiat Biol; 2009 Dec; 85(12):1148-56. PubMed ID: 19995240 [Abstract] [Full Text] [Related]
8. The relative biological effectiveness of antiprotons. Holzscheiter MH, Alsner J, Bassler N, Boll R, Caccia M, Knudsen H, Maggiore C, Petersen JB, Sellner S, Straße T, Singers Sørensen B, Overgaard J. Radiother Oncol; 2016 Dec; 121(3):453-458. PubMed ID: 27988058 [Abstract] [Full Text] [Related]
9. The antiproton depth-dose curve in water. Bassler N, Holzscheiter MH, Jäkel O, Knudsen HV, Kovacevic S. Phys Med Biol; 2008 Feb 07; 53(3):793-805. PubMed ID: 18199915 [Abstract] [Full Text] [Related]
10. Modelling carcinogenesis after radiotherapy using Poisson statistics: implications for IMRT, protons and ions. Jones B. J Radiol Prot; 2009 Jun 07; 29(2A):A143-57. PubMed ID: 19454805 [Abstract] [Full Text] [Related]
11. Should positive phase III clinical trial data be required before proton beam therapy is more widely adopted? No. Suit H, Kooy H, Trofimov A, Farr J, Munzenrider J, DeLaney T, Loeffler J, Clasie B, Safai S, Paganetti H. Radiother Oncol; 2008 Feb 07; 86(2):148-53. PubMed ID: 18237800 [Abstract] [Full Text] [Related]
12. On the clinical spatial resolution achievable with protons and heavier charged particle radiotherapy beams. Andreo P. Phys Med Biol; 2009 Jun 07; 54(11):N205-15. PubMed ID: 19436099 [Abstract] [Full Text] [Related]
13. Investigating the accuracy of the FLUKA code for transport of therapeutic ion beams in matter. Sommerer F, Parodi K, Ferrari A, Poljanc K, Enghardt W, Aiginger H. Phys Med Biol; 2006 Sep 07; 51(17):4385-98. PubMed ID: 16912388 [Abstract] [Full Text] [Related]
14. Real-time imaging for dose evaluation during antiproton irradiation. Kantemiris I, Angelopoulos A, Bassler N, Giokaris N, Holzscheiter MH, Karaiskos P, Kalogeropoulos TE, AD-4/ACE Collaboration. Phys Med Biol; 2010 Mar 07; 55(5):N123-31. PubMed ID: 20134083 [Abstract] [Full Text] [Related]
15. Direct comparison of biologically optimized spread-out bragg peaks for protons and carbon ions. Wilkens JJ, Oelfke U. Int J Radiat Oncol Biol Phys; 2008 Jan 01; 70(1):262-6. PubMed ID: 17935903 [Abstract] [Full Text] [Related]
16. Radiobiologic properties of pions and heavy ions. A comparison. Raju MR. J Can Assoc Radiol; 1980 Mar 01; 31(1):26-9. PubMed ID: 7364843 [Abstract] [Full Text] [Related]
17. Repair inhibition in tumours irradiated with fast protons and negative pions. Jüling-Pohlit L, Pohlit W, Blattmann H. Strahlenther Onkol; 1990 Jan 01; 166(1):6-9. PubMed ID: 2154049 [Abstract] [Full Text] [Related]
18. A Monte Carlo study for the calculation of the average linear energy transfer (LET) distributions for a clinical proton beam line and a radiobiological carbon ion beam line. Romano F, Cirrone GA, Cuttone G, Rosa FD, Mazzaglia SE, Petrovic I, Fira AR, Varisano A. Phys Med Biol; 2014 Jun 21; 59(12):2863-82. PubMed ID: 24828462 [Abstract] [Full Text] [Related]
19. Monte Carlo simulations for the shielding of the future high-intensity accelerator facility FAIR at GSI. Radon T, Gutermuth F, Fehrenbacher G. Radiat Prot Dosimetry; 2005 Jun 21; 115(1-4):212-5. PubMed ID: 16381714 [Abstract] [Full Text] [Related]